Vasoactive Intestinal Peptide Receptors: A Molecular Target in Breast and Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|11|1099-1104

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.11, 2007-04, pp. : 1099-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of G protein-coupled vasoactive intestinal peptide receptors in HIV integration

By Branch Donald R  

Future Virology, Vol. 6, Iss. 6, 2011-06 ,pp. : 741-753

Future Medicine

Access to resources Recommend Favorite

Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 661-666

Bentham Science Publishers

Access to resources Recommend Favorite

Vasoactive intestinal peptide family as a therapeutic target for Parkinson’s disease

By Gonzalez-Rey Elena   Chorny Alejo   Fernandez-Martin Amelia   Varela Nieves   Delgado Mario  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 923-929

Informa Healthcare

Access to resources Recommend Favorite

Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors

By Hannon J.P.   Langenegger D.   Waser B.   Hoyer D.   Reubi J.-C.  

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 165-173

Elsevier

Access to resources Recommend Favorite

Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle

By Ekblad E.   Sundler F.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 61-66

Elsevier

Access to resources Recommend Favorite